Significantly on the legislative activity has stemmed from Purdue Pharma's conclusion in 2011 to start a modification of Oxycontin's composition to really make it more difficult to crush for snorting or injecting. The brand new formulation, OxyNeo, is meant to generally be preventive in this regard and keep its efficiency being a painkiller. Due to